PRKAA2 and cancer: However, during tumor development processes, cancer cells are often in a state of metabolic stress (hypoxia, hormone deficiency, or radiochemotherapy, etc.), which activates a stress-response molecule AMPK, inhibiting anabolism and promoting catabolism to provide ATP, helping cancer cell escape the crisis (Park et al., 2009).